| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $27,6750 | +4,40% | $1,74B | $510,65K | |
SGRY Surgery Partners, Inc. Common Stock | $13,5000 | -1,96% | $1,74B | $1,41M | |
GAB The Gabelli Equity Trust Inc. | $5,6100 | -0,18% | $1,74B | $760,12K | |
HURN Huron Consulting Group Inc. | $104,76 | -1,74% | $1,74B | $165,54K | |
ENVX Enovix Corporation Common Stock | $8,2200 | -4,64% | $1,74B | $6,38M | |
PAYO Payoneer Global Inc. Common Stock | $5,0850 | -4,95% | $1,74B | $4,64M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9100 | -0,27% | $1,73B | $160,52K | |
STGW Stagwell Inc. Class A Common Stock | $6,5900 | -8,47% | $1,73B | $1,72M | |
CASH Pathward Financial, Inc. Common Stock | $77,6800 | -4,58% | $1,73B | $286,18K | |
SNDX Syndax Pharmaceuticals, Inc. | $18,3450 | -0,25% | $1,73B | $1,24M | |
STRA Strategic Education, Inc. Common Stock | $79,0400 | -0,15% | $1,73B | $176,47K | |
CAPR Capricor Therapeutics Inc | $27,6700 | +1,21% | $1,73B | $535,77K | |
AAPG Ascentage Pharma Group International American Depository Shares | $17,8250 | -3,39% | $1,73B | $22,13K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $8,1900 | -1,68% | $1,73B | $7,43M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $25,0000 | +2,97% | $1,73B | $261,41K | |
